Verso Corporation (NYSE:VRS) recently announced that the Strategic Alternatives Committee formed by its Board of Directors in September 2017 has now expanded its evaluation of potential transaction alternatives to include other alternatives, including but not limited to, a potential sale or merger of the entire company. Houlihan Lokey Capital has been assisting the company on the process.